Related Experiment Videos
Cyclophosphamide-induced glomerular injury in newborn mice
Laboratory Investigation; a Journal of Technical Methods and Pathology
|September 1, 1982
Summary
Cyclophosphamide exposure in newborn mice caused kidney damage, including mesangiolysis and sclerosis. This highlights the drug's potential to harm developing glomeruli and underscores the role of microfibrils in kidney repair.
Area of Science:
- Nephrology
- Developmental Biology
- Toxicology
Background:
- Cyclophosphamide is a widely used chemotherapy agent.
- Developing glomeruli may be susceptible to drug-induced injury.
- Glomerular microfibrils are implicated in kidney repair processes.
Purpose of the Study:
- To investigate the effects of cyclophosphamide on newborn mouse glomeruli.
- To examine the role of mesangial microfibrils in cyclophosphamide-induced glomerular injury and repair.
Main Methods:
- Newborn mice were administered intraperitoneal injections of cyclophosphamide.
- Glomeruli were examined for pathological changes such as mesangiolysis and sclerosis.
- The presence and distribution of mesangial microfibrils were analyzed.
Main Results:
- Cyclophosphamide induced varying degrees of mesangiolysis and sclerosis in glomeruli.
- Sclerosis was preceded by significant mesangial microfibril formation.
- Subendothelial widening of glomerular capillaries and increased microfibrils were observed.
Conclusions:
- Cyclophosphamide can cause significant injury to developing glomeruli in newborn mice.
- Glomerular microfibrils play a crucial role in the repair process following cyclophosphamide-induced damage.
- These findings provide insights into the nephrotoxic effects of cyclophosphamide during development.